KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Equity Average (2016 - 2025)

Historic Equity Average for Precigen (PGEN) over the last 13 years, with Q3 2025 value amounting to $2.5 million.

  • Precigen's Equity Average fell 9483.59% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 9483.59%. This contributed to the annual value of $78.5 million for FY2024, which is 3585.03% down from last year.
  • Precigen's Equity Average amounted to $2.5 million in Q3 2025, which was down 9483.59% from -$25.4 million recorded in Q2 2025.
  • Precigen's 5-year Equity Average high stood at $175.2 million for Q2 2023, and its period low was -$25.4 million during Q2 2025.
  • Its 5-year average for Equity Average is $96.1 million, with a median of $107.8 million in 2024.
  • In the last 5 years, Precigen's Equity Average soared by 17055.81% in 2023 and then tumbled by 13626.46% in 2025.
  • Precigen's Equity Average (Quarter) stood at $119.3 million in 2021, then grew by 12.66% to $134.4 million in 2022, then fell by 0.97% to $133.1 million in 2023, then crashed by 64.73% to $46.9 million in 2024, then plummeted by 94.58% to $2.5 million in 2025.
  • Its Equity Average stands at $2.5 million for Q3 2025, versus -$25.4 million for Q2 2025 and $12.2 million for Q1 2025.